Professional Resources
Clinical research, white papers, and professional resources supporting ProImmune® Immune Formulation 200®
A scientific overview for physicians, pharmacists, and clinical professionals.
“A scientifically grounded glutathione-precursor formulation, researched by $88M NIH research grant under 18 universities proven to be more effective than glutathione or NAC is now entering national awareness through clinician experience and modern distribution.”
Glutathione (GSH) plays a central role in cellular antioxidant defense, redox regulation, and immune resilience. Traditional supplementation approaches—including N-acetylcysteine (NAC)—primarily supply cysteine precursors, yet clinical and biochemical limitations remain, particularly under high oxidative stress.
ProImmune® IF200 is a cystine- and glutamine-based precursor formulation developed by Albert B. Crum, MD, designed to support intracellular glutathione synthesis and activate the Nuclear factor erythroid 2–related factor 2 (Nrf2) gene, a master regulator of cellular antioxidant defenses. The formulation provides multiple rate-limiting substrates and cofactors simultaneously, including cystine, glutamine, glycine, selenium, and complementary amino acids.
Although formal peer-reviewed clinical trials remain limited, in-vitro research and extensive real-world physician feedback suggest that cystine- and glutamine-based formulations may outperform NAC under oxidative stress and support endogenous antioxidant gene activation through Nrf2.
Glutathione (γ-glutamyl-cysteinyl-glycine) is the body’s primary intracellular antioxidant and a key regulator of redox homeostasis. Deficiencies or inefficiencies in glutathione recycling are associated with:
Restoring glutathione levels and activating cellular defense genes such as Nrf2 are complementary strategies for maintaining cellular resilience. NAC supplementation is widely used but may be insufficient when multiple pathways are stressed.
ProImmune® IF200 provides coordinated support for GSH synthesis and Nrf2 activation, enhancing cytoprotective responses.
2.1. Dr. Albert B. Crum, MD
Dr. Crum is an accomplished physician-scientist known for decades of research into glutathione biochemistry, oxidative stress, and immune regulation. His work emphasized:
His formulations, originally referenced under names such as F1, FFAAP, ProThione, Immune Formulation, and IF200, were distributed quietly among clinicians for many years before gaining commercial visibility.
3.1. Limitations of NAC
NAC provides cysteine but:
3.2. Cystine and Glutamine Advantage
Cystine and glutamine:
3.3. Nrf2 Activation
Nrf2 (Nuclear factor erythroid 2–related factor 2) is a transcription factor regulating genes involved in:
ProImmune® IF200 has been shown in laboratory studies to activate Nrf2-regulated pathways, increasing intracellular antioxidant capacity and enhancing cytoprotective mechanisms.
3.4. Multi-Substrate Support
ProImmune® IF200 includes:
This multi-substrate approach optimizes rate-limiting steps in both glutathione synthesis and Nrf2-mediated antioxidant gene expression.
Studies on cystine- and glutamine-based precursors demonstrate:
These findings suggest mechanistic advantages under oxidative and inflammatory challenges.
(Reference: in vitro vascular smooth muscle cell studies; product names not disclosed in publications.)
5.1. Physician Observations
Clinicians report:
5.2. Case Reports
Some case studies report recovery with “glutathione precursor therapy,” including Dr. Edward Fogarty’s dementia reversal case. Although ProImmune was used, the publication described “glutathione precursors” to maintain neutrality.
5.3. Customer Feedback
At TheBestImmuneSupport.com, customers report:
These testimonials are consistent, though anecdotal.
ProImmune® IF200 represents a mechanistically grounded approach to antioxidant support by:
Real-world physician and consumer feedback supports its potential efficacy. Its historical under-publication explains why broader scientific awareness is only now emerging. Controlled trials are warranted to quantify clinical outcomes.
TheBestImmuneSupport.com — U.S. Distribution and Professional Support
(Owned and operated by Joseph V. Cassarino)
Oxidation is interpreted physiologically as the deterioration or breakdown of a molecule.
How does a breakdown take place? The breakdown takes place by taking the electrons away from the molecule. The electrons guard the nucleus. So that is called oxidation and that is what takes place with oxidative stress.
The electrons circulate around the nucleus and guard the nucleus and keep it intact. When you take away the electrons, you create oxidative stress and it is creating a biomarker of oxidative stress when you remove the electrons. The biomarker stimulates the Nrf2 Gene to produce Nrf2 for rescue! The pharmaceutical companies use toxins such as Bardoxolone methyl (a semi-synthetic triterpenoid compound) in order to stimulate the biomarker for oxidative stress in order to bring forth the Nrf2 Gene.
How does the ProImmune all-natural method of Nrf2 activation differ from the synthetic methods and how does L-Cysteine become L-cystine? By removal of an electron, it should be classified as oxidation but why isn’t it oxidation? Because it doesn’t deteriorate or break down the molecule. It goes from L-cysteine to L-Cystine because it protects the L-Cystine. In the process of removing the electron utilizing ProImmune, it creates a physiological biomarker to activate the Nrf2 Gene. Only the ingredients of ProImmune activate Nrf2 activation naturally within the body without utilizing outside forces not natural or inside the body.
If the PDF does not display, click here to download the White Paper.
Click image to view full size
Click image to view full size
PowerPoint presentation with research findings presented to the Department of Defense.
Download DocumentComprehensive overview of ProImmune and its science-backed formulation.
Download DocumentEducational resource on intracellular glutathione synthesis and immune support.
Download DocumentIf the PDF does not display, click here to download the ZIKA study.
Professional dosage guidelines for Immune Formulation 200®.
Download DocumentBy Dr. Albert B. Crum, M.D., DSc, (Hon), M.S. — Harvard Medical School Graduate
ProImmune® has been on the market globally since 2008 and provides certain advantages that can support your hyperbaric treatment projects. This discovery entails using ProImmune’s Free Form Amino Acid Precursors™ (FFAAP™). This product does not require catabolism before it is utilizable in the synthesis of Glutathione.
As you well understand, oxygen therapy increases cellular metabolism and thus produces waste products via oxidative stress. That is where the unity of restoration purpose with Glutathione — especially the precursors to Glutathione, known as ProImmune® - Immune Formulation 200® — is so helpful with HBOT! The Glutathione remediates the oxidative stress and scavenges the waste products by neutralizing the open valences in the process that are caused by the heightened metabolism of oxidative stress.
Those open valences are a necessary consequence of oxygen therapy with its increase in metabolism. This is where the efficiency of ProImmune can be very helpful and useful in the restoration process. Incorporating ProImmune® could optimize health to unprecedented levels by incorporating ProImmune® before and after HBOT.
The method of action would simply be to deposit two to three regular scoops of Immune Formulation 200® on the patient’s tongue and almost immediately the Free Form Amino Acid Precursors™ enter the bloodstream and into the cellular synthesis of Glutathione. A scooper is included in each jar. ProImmune is also effective at mitigating heavy metals, gadolinium, glyphosate and microplastics directly inside cells. Nothing foreign to a cell can exist inside the cell when glutathione or oxygen levels are in optimal range.
— Albert B. Crum, M.D., DSc, (Hon), M.S. — Harvard Medical School Graduate
For additional information contact: Mr. Joseph V Cassarino at info@TheBestImmuneSupport.com or via cell at: 845-206-8104.
Download the full document by Dr. Albert B. Crum, M.D.
Download DocumentClick image to view full size
Written by Dr. Edward F. Fogarty, MD and Dr. Paul G. Harch, MD
Visit HBOT.com to learn more about Harch Hyperbaric Center.
If the PDF does not display, click here to download the case report.
Authorized Distributor for ProImmune Co. LLC
The content on this page is intended for educational & research purposes only. Please research all facts to confirm and always consult with your doctor or medical provider before adding any supplementation, especially if you are pregnant or nursing.
NOTE: The FDA does not label or allow any supplement as FDA approved.
* These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease.